The American Gastroenterological Association (AGA) released a new clinical practice guideline on the surveillance of Barrett's esophagus, the only known precursor to esophageal cancer (adenocarcinoma) ...

Publishers Warner Bros. Games and Atari, and developers Nightdive Studios and Monolith Productions have announced Blood: Refreshed Supply for the Nintendo Switch 2, PlayStation 5, Xbox Series X|S, ...

Esophageal cancer is classified into adenocarcinoma and squamous cell carcinoma, with dysphagia as a common symptom. Diagnosis involves endoscopy, biopsy, and imaging to confirm cancer presence and ...

Nightdive is back again with another first-person shooter of yesteryear to put back in front of people’s faces. This time it’s Blood, again! The Build Engine classic is getting another remaster, ...

The last weeks of summer often mean family cookouts, fun vacations and late nights hanging out with friends before school starts. I learned recently that it’s also one of the most critical times for ...

Blood: Refreshed Supply is the definitive remaster of the 1997 cult classic shooter dripping with Lovecraftian atmosphere and chunks of crimson viscera that's set to engorge players with new content.

Blood: Refreshed Supply is the definitive remaster of the 1997 cult classic shooter that’s set to engorge players with new content and eviscerate consoles for the first time. Officially licensed by ...

Here's your look at the Blood: Refreshed Supply announcement trailer for this upcoming remaster of the 2.5 FPS shooter game, Blood: Fresh Supply. Blood: Refreshed Supply features new content and ...

Nightdive Studios has announced an updated version of their remaster of Blood: Fresh Supply with Blood: Refreshed Supply. Nightdive Studios has made a name for itself recently for remastering some ...

James grew up in the arcades of the 80s and has played games on everything from the Milton Bradley Microvision to the PlayStation 5. He worked in gaming retail during the PS1/PS2 eras, and even had a ...

A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the burden of lifelong transfusions. A single one-time gene therapy could free ...